Keros Therapeutics, Inc. (KROS)

14.19 -0.84 (-5.59%) USD  |  NASDAQ  |  Feb 27, 16:00
14.19 0.00 (0.00%) After-Hours: 20:00
More

Keros Therapeutics Stock Based Compensation (5 Year Growth)

Stock Based Compensation (5 Year Growth) Chart

View Stock Based Compensation (5 Year Growth) for KROS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (5 Year Growth) Range, Past 5 Years

View Stock Based Compensation (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (5 Year Growth) Benchmarks

View Stock Based Compensation (5 Year Growth) Benchmarks
Start Trial
Amicus Therapeutics, Inc. Upgrade
MannKind Corp. Upgrade
Sarepta Therapeutics, Inc. --
Insmed, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade